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Abstract
Background: The human chromosome 14 microRNA cluster (C14MC) is a conserved microRNA (miRNA) cluster
across eutherian mammals, reported to play an important role in placental development. However, the expression
kinetics and function of this cluster in the mammalian placenta are poorly understood. Here, we evaluated the
expression kinetics of the equine C24MC, ortholog to the human C14MC, in the chorioallantoic membrane during
the course of gestation.
Results: We demonstrated that C24MC-associated miRNAs presented a higher expression level during early stages
of pregnancy, followed by a decline later in gestation. Evaluation of one member of C24MC (miR-409-3p) by in situ
hybridization demonstrated that its cellular localization predominantly involved the chorion and allantoic
epithelium and vascular endothelium. Additionally, expression of predicted target transcripts for C24MC-associated
miRNAs was evaluated by RNA sequencing. Expression analysis of a subset of predicted mRNA targets showed a
negative correlation with C24MC-associated miRNAs expression levels during gestation, suggesting the reciprocal
control of these target transcripts by this miRNA cluster. Predicted functional analysis of these target mRNAs
indicated enrichment of biological pathways related to embryonic development, endothelial cell migration and
angiogenesis. Expression patterns of selected target mRNAs involved in angiogenesis were confirmed by RT-qPCR.
Conclusion: This is the first report evaluating C24MC kinetics during pregnancy. The findings presented herein
suggest that the C24MC may modulate angiogenic transcriptional profiles during placental development in the
horse.
Keywords: C14MC, microRNA, mRNA, Transcriptome, microRNA-cluster, Human chromosome 14, Pregnancy,
Angiogenesis, Equine chromosome 24, Mare
Background
Small non-coding RNAs (ncRNAs) constitute a group of
RNAs which do not encode for proteins, but instead
modify the expression of protein-coding mRNAs [1]. In
plants and animals, microRNAs (miRNA) were one of
the first identified families of regulatory ncRNAs [2, 3].
MiRNAs are single-stranded small RNAs, approximately
22 nucleotides in length, that post-transcriptionally
modulate protein-coding genes [4]. These ncRNAs regu-
late numerous cellular processes such as metabolism,
cell proliferation, apoptosis, and cell differentiation in al-
most all cell types. The full or partial complementarity
of base pairs between miRNA and their respective target
mRNA lead to degradation or blocking the translation of
the target mRNAs [4–6].
One of the unique features of miRNAs is that they can
be transcribed as clusters. A miRNA cluster is a group
of two or more miRNAs which are transcribed from
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physically adjacent miRNA genes in the same orientation
[7, 8]. These miRNA clusters are exclusively or preferen-
tially expressed in a tissue-specific manner [9]. Recent
reports have described several miRNA clusters expressed
in human placenta, including the chromosome 14 miRNA
cluster (C14MC), the chromosome 19 miRNA cluster
(C19MC) and the miR-371-3 cluster also located in
chromosome 19 [9–12]. The C19MC is exclusively found
in primates while C14MC appears to be conserved among
all eutherian species studied so far [12]. To date, the ex-
pression of miRNA clusters in equine placenta has not
been reported.
The chromosome 14 miRNA cluster is one of the lar-
gest miRNA clusters transcribed in human and mouse
(C12MC) placenta and consists of over 50 miRNAs.
This cluster was originally described as two families lo-
cated within two closely neighboring segments span-
ning about 40 kb [12–14]. The expression of C14MC has
a tissue-specific pattern in mice and in humans [9, 14]. In
mice, C12MC is mostly expressed in the head and trunk
of the developing embryo and it is restricted to the brain
and placental tissues in the adult mice [14]. In healthy
humans, expression of the C14MC is predominantly lim-
ited to the placenta and other tissues of epithelial origin
[9]. The expression of C14MC was also observed in ab-
normal tissues in humans and mice, as potential tumor
suppressor factors in gastric and liver cancers, mainly by
inhibiting cell migration and invasion [15–17]. Currently,
the tissue-specific expression of this cluster has not been
characterized in species other than humans and mice.
While eutherian mammals have a wide diversity in
the morphology of their placenta, the orthologous
miRNA clusters are conserved without significant
structural changes in all sequenced genomes and ap-
pear to be maintained in evolution for approximately
100 million years [13]. It has been suggested that the
emergence of the C14MC was one of the factors that
facilitated evolution of the mammalian placenta and
may play important biological roles in placental and
embryonic development [13, 18]. For instance, the import-
ance of the murine C12MC, orthologous to C14MC, has
been experimentally verified in a mouse model by deletion
of this cluster, which led to neonatal lethality [19]. The
C12MC-associated miRNA knockout mice showed pla-
cental over growth and a defective feto-maternal interface
[20, 21]. In contrast, overexpression of C12MC-associated
miRNAs was associated with growth retardation and
postnatal lethality [22]. Although the C14MC has been
reported to play an important role in placental develop-
ment, its expression kinetics and its functions are
poorly understood. Morales-Prieto et al. described the
expression of miRNAs within C14MC in human tropho-
blast cells and showed a significant decrease in the expres-
sion levels of this cluster between first to third trimester
of pregnancy, suggesting a strong decline in the expres-
sion of C14MC with advancing gestational age in humans
[11]. Gu et al. also demonstrated that expression of miR-
NAs within C14MC was significantly upregulated in the
first trimester human placenta in comparison to postpar-
tum placental samples [23]. These studies investigated the
expression of C14MC at only two time-points due to lim-
ited sample availability, so there is minimal information
on the kinetics of this cluster throughout pregnancy.
Characterizing the expression pattern of miRNAs during
physiological and pathological conditions is an important
first step to investigate the function of this critical miRNA
cluster.
We hypothesized that equine C24MC-associated
miRNAs, the ortholog of human C14MC, have a differ-
ential expression pattern in chorioallantoic membrane
(CAM) during different stages of gestation. In the
present study, we determined the expression pattern of
equine C24MC-associated miRNAs in CAM during preg-
nancy. We further analyzed the predicted functions of this
cluster by generating a corresponding RNA-sequencing
dataset from corresponding CAM. Additionally, we ana-
lyzed the cellular localization of one member of this clus-
ter (eca-miR-409-3p) throughout gestation in equine
CAM by in situ hybridization (ISH). This study identified
that the expression of C24MC-associated miRNAs is
downregulated during the course of gestation and deter-
mined the cellular localization of one of its members.
Furthermore, we showed the presence of a negative cor-
relation between the expression profile of these miRNAs
and that of their putative mRNA targets, predicted to be
functionally involved in embryonic development, endothe-
lial cell migration and angiogenesis. Further studies to
characterize the functions of each member of this miRNA
cluster during placental development are warranted.
Methods
Animal use
The horses (Equus caballus) used in this study were
mixed-breed ranging between 250 and 550 kg and four
to sixteen years of age. Mares were born and raised at
University of Kentucky research farm and housed on
pasture with ad libitum grass hay. Gestational age was
determined based on the day of ovulation (day 0).
CAM collection and preparation
Samples of CAM (n = 29) were collected from pregnant
mares at 45 days (45d, n = 9), four months (4mo, n = 7),
six months (6mo, n = 4) and ten months of gestation
(10mo, n = 6), as well as from the CAM after normal
parturition (n = 3, postpartum). For collection of CAM
samples (except for CAM at 45d and postpartum), the
uterus of pregnant mares was recovered immediately
after euthanasia (using a barbiturate overdose following
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the American Veterinary Medical Association [AVMA]
guidelines for the euthanasia of animals), the CAM was
carefully separated from the endometrium, and full
thickness CAM were collected from the body of the
placenta. The CAM samples at 45d were retrieved from
conceptuses collected by uterine lavage. The postpar-
tum samples were collected immediately after normal
parturition.
Collected CAM samples were stored overnight at 4 °
C in RNAlater™ (Life Technologies, Carlsbad, CA) and
then stored at − 80 °C until further processed. The
remaining tissue samples were fixed in 10% formalde-
hyde for 24 h, transferred to 70% methanol and paraffin
embedded following standard histological procedures
[24]. Histological sections were stained with hematoxylin
and eosin following routine procedures and assessed
to confirm normal CAM without any contamination
from endometrium. The study overview is presented
in Fig. 1.
MiRNA extraction, cDNA synthesis and qPCR
CAM samples were thawed on ice and total RNA was
extracted with Trizol™ (Life Technologies, Carlsbad,
CA) following the manufacturer’s recommendations.
Total RNA concentration was measured using a Nano-
Drop DP-1000 spectrophotometer (ThermoFisher Scien-
tific, Waltham, MA).
Complementary DNA synthesis was carried out using the
miScript II RT Kit (Qiagen, Hilden, Germany). The reaction
carried out in 20 μL reverse transcription reaction mixture
consisted of 2 μL of extracted RNA (containing 400 ng of
RNA), 4 μL of miScript HiSpec buffer, 2 μL of miScript
Nucleics mix, 10 μL of RNase-free water and 2 μL of miS-
cript Reverse Transcriptase mix. Three μL of cDNA prod-
uct from each sample were combined to make the pooled
CAM sample. Pooled samples were only used as RT-qPCR
inter-plate controls as previously described [25].
The expression of mature miRNAs was determined by
RT-qPCR using the miScript SYBR Green PCR kit (Qiagen,
Fig. 1 Analysis workflow carried out in this study. CAM, chorioallantoic membrane; C24MC, chromosome 24 microRNA cluster; mRNA-seq, mRNA
sequencing; miRNA-seq, microRNA sequencing; ISH, in situ hybridization; RT-qPCR, UTR, untranslated region
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Hilden, Germany) with the miScript Universal Primer
along with miRNA-specific primers according to the
manufacturer’s guidelines. The reaction consisted of 1
ng (1 μl) of cDNA added to a reaction volume (9 μl)
containing 2X QuantiTect SYBR® Green PCR Master
Mix (5 μl), 10X miScript Universal Primer (1 μl), assay
specific primers (1 μl of a 5 μM stock, final concentra-
tion 0.5 μM), and RNase free water (2 μl). The cycling
conditions included an initial PCR activation step (95 °C
for 15min), followed by 40 cycles of denaturation at 94 °C
for 15 s, annealing at 55 °C for 30 s, and extension at 70 °C
for 30 s. A DNA melting curve was generated to discrim-
inate between specific and non-specific amplification
products. Primers were designed using miRprimer soft-
ware (version 2.0) for 30 candidate miRNAs [26]. The can-
didate miRNAs were selected in three steps:
(i) Based on prediction of C24MC in miRBase.org
(miRbase.v.21) (EquCab2.0), 46 distinct miRNAs are
included in this cluster with an inter-miRNA dis-
tance of less than 10 kb (EquCab2.0). The compara-
tive list of C14MC in domestic animals is presented
in the Additional file 1: Table S1.
(ii) Based on our previously generated Illumina miRNA-
sequencing dataset of equine CAM, we narrowed the
predicted miRNA list (Gene Expression Omnibus
[GEO, NCBI, NIH] Accession GSE113142). Presence
of all the predicted C24MC-associated miRNAs
(based on miRBase.org) were confirmed in the
CAM with the miRNA-sequencing dataset from
4mo (n = 3), 10mo (n = 3) and postpartum (n = 3).
Information about miRNA-sequencing, mapping,
normalization and statistical analysis are provided in
the supplementary section (Additional file 2 and
Additional file 3: Table S3 and Additional file 4: Table
S4). Primers were designed for the 11 miRNAs that
showed significant differences between the examined
time points (P < 0.05) and for the 17 most abundant
miRNAs (primers for a total of 28 miRNA targets
were designed).
(iii)Based on a literature search, two additional
miRNAs (hsa-miR-154 and hsa-miR-1247) were
added to the list of candidate miRNAs [11, 12, 23].
Hsa-miR-154 belongs to the human C14MC and
the equine orthologous miRNA has not been
reported in miRBase database even though it was
expressed in our miRNA-sequencing dataset.
Similarly, hsa-miR-1247 was added to the candidate
miRNAs since it has been jointly studied with the
C14MC even though it is expressed from the oppos-
ite DNA strand [14]. It has been shown that the ex-
pression of these miRNAs change significantly during
both normal and abnormal pregnancy conditions in
human [27, 28].
The list of miRNA candidates and primer sequences
are provided in Table 1. Primer efficiency was verified
on the pooled samples. Primers with CT values < 35
that did not produce primer-dimers were used for fur-
ther experimentation. Otherwise, primers were
re-designed and re-tested. Eca-miR-106a, eca-miR-
8908a and eca-miR-369-5p were used as reference
genes [25]. Real-Time qPCR was performed in triplicate
for all samples, and geometric mean for the triplicate was
calculated and used for further analysis [25, 29–31]. PCR
efficiencies were calculated using LinRegPCR (version
2012.0) (http://www.hartfaalcentrum.nl) to ensure that
all primers resulted in PCR efficiencies between 1.8
and 2.1.
Total RNA isolation, library preparation and RNA-sequencing
(RNA-seq)
A subset of CAM samples from 45d, 4mo, 6mo, and
10mo (n = 4, at each time point) were thawed on ice and
total RNA was extracted using the RNeasy Mini Kit
(Qiagen) per manufacturer’s instructions. After extrac-
tion, RNA was analyzed by NanoDrop® (Thermo Fisher
Scientific) and Bioanalyzer® (Agilent, Santa Clara, CA,
USA) to evaluate concentration, purity and integrity of
recovered RNA. All samples had a 230/260 ratio > 1.8, a
260/280 ratio > 2.0 and an RNA integrity number > 8.0
(mean ± STD = 9.2 ± 0.4).
Library preparation was performed using the TruSeq
Stranded mRNA Sample Prep Kit (Illumina, San Diego,
CA, USA) per manufacturer’s instructions. The adapter
for Read 1 was AGATCGGAAGAGCACACGTCTGAA
CTCCAGTCACNNNNNNATCTCGTATGCCGTCTTC
TGCTTG, with NNNNNN being the index sequence.
The read 2 adapter was AGATCGGAAGAGCGTCGTG
TAGGGAAAGAGTGTAGATCTCGGTGGTCGCCGTA
TCAT. The libraries were quantified by qPCR. Sequen-
cing was performed on a HiSeq 4000 (Illumina) using a
HiSeq 4000 sequencing kit version 1, generating 150 bp
paired-end reads. FASTQ files were generated and demul-
tiplexed using bcl2fastq v2.17.1.14 Conversion Software
(Illumina).
For RNA-seq data analysis, the reads were initially
trimmed for adapters and quality using TrimGalore Ver-
sion 0.4.4 (Babraham Bioinformatics; www.bioinforma-
tics.babraham.ac.uk), then trimmed reads were aligned to
the horse reference genome (EquCab2.1) using STAR
(Release 2.5.2b) [32], and annotated to the equine refer-
ence transcriptome available in Ensembl database (Equ-
Cab2.88; www.ensembl.org) using Cufflinks (Release 2.2.1;
http://cole-trapnell-lab.github.io/cufflinks/) [33]. Differen-
tial expression analysis was performed on the normalized
read count (FPKM; fragments per kilobase of exon per
million mapped reads) [34].
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MiRNA target prediction
To assess pathways that might be affected by the
C24MC-associated miRNAs, predicted targets of differ-
entially expressed miRNAs were assessed using Ingenu-
ity Pathway Analysis (IPA; Qiagen, Redwood City, CA,
USA; Release December 2017). The miRNA and mRNA
pairing was performed using the miRNA expression
values (evaluated by RT-qPCR) and normalized read
counts (RNA-seq dataset) using IPA’s microRNA Target
Filter, respectively. This allows predicting the function for
the miRNAs according to the provided datasets (RNA--
seq) (www.ingenuity.com/products/IPA/microRNA.html).
Only target mRNAs that were previously (experimentally)
confirmed or predicted with high confidence (IPA scoring
system) were selected as putative targets. In addition to
IPA predicted targets, putative targets were also identified
using miRDB (http://mirdb.org), and mRNAs with a target
prediction score (TPS) of ≥80 were added to the putative
target list [35].
Since miRNAs mainly down regulate their target mRNA
expression [36, 37], those mRNAs in the RNA-seq data
set which exhibited the reverse pattern of expression when
compared to the miRNA expression pattern were selected
for further analysis. The negative correlation (r ≤ − 0.5,
P < 0.05) between the expression pattern of putative
target mRNAs and that of their corresponding miRNA
was analyzed during gestation (45d, 4mo, 6mo, 10mo;
significance set at P-value < 0.05) and those target
mRNAs presenting a significant negative correlation
with the expression pattern of their corresponding
miRNA were selected for canonical pathway and func-
tional analysis [38]. The canonical pathways and func-
tional analysis for the target mRNAs were performed
using IPA and biological functions of the target mRNA
Table 1 List of selected C24MC-associated miRNAs evaluated by RT-qPCR and their respective primer sequences
MiRNA ID Accession IDa Mature sequence Forward Primer
eca-miR-127-5p MIMAT0004604 cugaagcucagagggcucugau ctgaagctcagagggct
eca-miR-134-5p MIMAT0013127 ugugacugguugaccagagggg gcagtgtgactggttgac
eca-miR-323-3p MIMAT0013132 cacauuacacggucgaccucu gcagcacattacacggt
eca-miR-323-5p MIMAT0013131 aggugguccguggcgcguucgc ccgtggcgcgtt
eca-miR-369-3p MIMAT0013141 aauaauacaugguugaucuuu cagcgcagaataatacatggt
eca-miR-370-3p MIMAT0013142 gccugcugggguggaaccuggu cctgctggggtgga
eca-miR-370-5p MIMAT0026483 caggucacgucucugcaguuac cagcaggtcacgtctct
eca-miR-379-5p MIMAT0013147 ugguagacuauggaacguagg cagtggtagactatggaacg
eca-miR-382-5p MIMAT0013150 gaaguuguucgugguggauucg aggaagttgttcgtggtg
eca-miR-3958-3p MIMAT0034486 cagauauugcacgguugaucucuu gcagatattgcacggttga
eca-miR-3958-5p MIMAT0019275 agguuguccgugauguauuugc agaggttgtccgtgatgt
eca-miR-409-3p MIMAT0013152 gaauguugcucggugaaccccu aggaatgttgctcggtga
eca-miR-411-3p MIMAT0013154 uauguaacacgguccacuaacc cagtatgtaacacggtccac
eca-miR-411-5p MIMAT0003329 uaguagaccguauagcguacg cagtagtagaccgtatagcgt
eca-miR-412-3p MIMAT0013155 uucaccugguccacuagccg gcagttcacctggtcca
eca-miR-412-5p MIMAT0026557 uggucgaccaguuggaaaguaau cagtggtcgaccagttg
eca-miR-432-5p MIMAT0013157 ucuuggaguaggucauugggugg cagtcttggagtaggtcattg
eca-miR-433-3p MIMAT0013158 aucaugaugggcuccucggugu catgatgggctcctcg
eca-miR-485-3p MIMAT0013160 gucauacacggcucuccucucu gcaggtcatacacggct
eca-miR-485-5p MIMAT0013159 agaggcuggccgugaugaauuc ggctggccgtgatga
eca-miR-487a-5p MIMAT0026559 gugguuaucccugcuguguucg caggtggttatccctgct
eca-miR-487b-3p MIMAT0013162 aaucguacagggucauccacuu cagaatcgtacagggtcatc
eca-miR-493b-5p MIMAT0002813 uuguacaugguaggcuuucauu gcgcagttgtacatggtag
eca-miR-543-3p MIMAT0013169 aaacauucgcggugcacuucuu gcagaaacattcgcggtg
hsa-miR-1247-3p MIMAT0022721 ccccgggaacgucgagacuggagc cgggaacgtcgagac
hsa-miR-154-5p MIMAT0000452 uagguuauccguguugccuucg gcagtaggttatccgtgttg
amirbase.org; Release 21
Primers were designed using miRprimer software (version 2.0)
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were analyzed by Protein ANalysis THrough Evolution-
ary Relationships Classification System (PANTHER;
Release 13.1) ontology classification system [39].
Confirmation of angiogenic gene expression by reverse
transcription and quantitative real-time PCR
RNA was isolated from CAM (n = 29) at 45d (n = 9),
4mo (n = 7), 6mo (n = 4) and 10mo (n = 6) of gestation,
as well as from the CAM after normal parturition (n =
3, postpartum) using the RNeasy Mini kit per manu-
facturer’s instructions, including an on-column DNase
treatment. RNA concentration was analyzed by Nano-
Drop®. All samples had a 230/260 ratio > 1.8 and a
260/280 ratio > 2.0 and RIN values > 8 (mean ± STD =
9.2 ± 0.4).
RNA was reverse-transcribed using TaqMan™ Reverse
Transcription Reagents (#4368814; Invitrogen™). The re-
action (20 μl) included 10 μl of total RNA (2 μg), 2 μl of
10X RT Buffer, 0.8 μl 25X dNTP Mix (100 mM), 2 μl of
10X RT Random Primers, 1 μl of Reverse Transcriptase,
1 μl of RNase inhibitor and 3.2 μl of nuclease-free water.
The reverse transcription reaction was incubated for 10
min at 25 °C, followed by 120 min incubation at 37 °C
and a final step at 85 °C for 5 min. cDNA was diluted 1:5
in nuclease-free water and stored at − 20 °C until used.
RT-qPCR was performed using PowerUp™ SYBR™
Green Master Mix (#A25741; Applied Biosystems™) for
activin A receptor like type 1 (ACVLR1), AXL receptor
tyrosine kinase (AXL), C-X-C motif chemokine ligand
10 (CXCL10), dishevelled segment polarity protein 1
(DVL1), endothelin receptor type A (ENDRA), epsin 2
(EPN2), glucose-6-phosphate dehydrogenase (G6PD), junc-
tion adhesion molecule 2 (JAM2), neuropilin 1 (NRP1) and
TYRO3 protein tyrosine kinase 3 (TYRO3), which were
predicted in our dataset to be involved in angiogenesis
(Primer sequences can be found in Additional file 5:
Table S5). Briefly, 1 μl (1 ng) of cDNA was added to a
reaction volume (9 μl) containing 2X PowerUp™ SYBR™
Green Master Mix (5 μl), assay-specific forward and re-
verse primers (0.25 μl of a 20 μM stock, final concentra-
tion 0.5 μM for each primer) and RNase-free water
(3.5 μl). The cycling conditions included an initial UDG
(50 °C for 2 min) and PCR activation steps (95 °C for 2
min) followed by 40 cycles of denaturation at 95 °C for
15 s and annealing/extension at 60 °C for 1 min. Melt
curve analysis was performed to check for non-specific
amplifications along with the inclusion of non-template
controls. Reactions were performed in duplicate and
GAPDH, ACTB and GUSB were used as housekeeping
genes [40, 41]. PCR efficiencies were calculated using
LinRegPCR (version 2012.0) (http://www.hartfaalcentrum.nl)
to ensure that all primers resulted in PCR efficiencies
between 1.8 and 2.1.
Analysis of putative miRNA:mRNA binding sites for
selected angiogenic genes
For further analysis of potential miRNA:mRNA interac-
tions, identification of the miRNA binding site at the 3’
UTR of the selected equine angiogenic genes was per-
formed. 3’ UTR sequences of the genes which were
shown to be involved in angiogenesis in our dataset
were retrieved from NCBI and the binding site was
identified using IntaRNA 2.0 (Freiburg RNA Tools,
Universität Freiburg, Germany) [42, 43]. The free en-
ergy (ΔG) of the predicted miRNA:mRNA interaction
was estimated using the RNAhybrid tool (Universität
Bielefeld, Germany) [44].
MiRNA localization by in situ hybridization
The expression pattern of eca-miR-409-3p was further in-
vestigated by chromogenic ISH using a dual digoxigenin
(DIG)-labeled LNA™ probe specific to hsa-miR-409-3p
(610701-360; miRCURY LNA™, Exiqon, Vedbaek,
Denmark). In addition, a dual DIG-labeled LNA™ probe
specific to U6 snRNA (#699002-360; Exiqon) and a
scrambled miRNA probe (#699003-360; Exiqon) were
used as positive and negative controls, respectively. The
sample set evaluated included CAM from 45d (n = 2), 4
mo (n = 2), 6 mo (n = 2), 10 mo (n = 2), and postpartum
(n = 2). The ISH assay was performed as recommended
by the manufacturer. Briefly, five-micrometer sections
of formalin-fixed, paraffin-embedded tissues were
mounted on positively charged Superfrost® Plus slides
(Fisher Scientific, Pittsburgh, PA), dried overnight at
37 °C, and subjected to deparaffinization in xylenes
followed by rehydration through an ethanol dilution
series and 1X phosphate buffered saline. Automated ISH
was performed in a Ventana Discovery Ultra (Ventana
Medical Systems, Inc. AZ, USA). The tissue sections were
digested with 10 μg/ml of proteinase K for 16min at room
temperature and hybridized with the respective probes
(diluted to 40 nM for hsa-miR-409-3p and scrambled
miRNA probes, or 0.1 nM for U6 snRNA probe in DIS-
COVERY ISH diluent (Ventana)) for two hours at 50 °C.
Stringency washes were performed with RiboWash
(Ventana). The bound dual-labeled probe was detected
with an alkaline phosphatase-conjugated polyclonal
anti-DIG antibody (DISCOVERY anti-DIG AP Multi-
mer, Ventana) after a 15 min blocking step using the
DISCOVERY Antibody Block (Ventana), and the signal
was detected using nitro blue tetrazolium chloride/5-bro-
mo-4-chloro-3-indolyl-phosphate (NBT-BCIP; Chromo-
Map Blue Kit, Ventana) as the substrate. The sections
were incubated with the substrate for two hours and
counterstained using the Red Counterstain II (Ventana)
for 8 min. Sections were finally dehydrated in successive
alcohols and mounted using permanent mounting
medium (Eukitt®, Sigma-Aldrich, St. Louis, MO). ISH
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signal was evaluated and quantified by two different inves-
tigators blinded to gestational age with a Zeiss operative
microscope equipped with MicroPublisher 5.0 RTV cam-
era (Q-Imaging, Burnaby, BC, Canada). For quantification
purposes, sections were scored as follows: 0, no staining;
1, weak or minimal staining; 2, mild staining; 3, moderate
staining; 4, intense or abundant staining.
Statistical analysis
Delta CT (ΔCT) values for CAM samples were calculated
where ΔCT = (CT values of miRNA of interest - Geometric
mean of the CT values of all three reference miRNAs)
[31, 45]. CAM results are presented as -ΔCT (negative
ΔCT is more intuitive than ΔCT). Graphs were made in
JMP (SAS Institute, version 12.1.0) and “d3heatmap”
or “plot” packages in R (version 1.0.136) [46].
Statistical analyses were performed in SAS version 9.2
(SAS Institute Inc., Cary, NC, USA, 2010). Normality of
the data (-ΔCT, microRNA-read counts, and FPKM) was
verified using “PROC UNIVARIATE”. Normal quantile
transformation was performed to normalize the data
[47]. MiRNA expression levels (-ΔCT) were compared
between pregnancy stages using the mixed model by
“PROC MIXED”, where stage of pregnancy was set as
the fixed effect and animal was set as the random effect
[48]. Post hoc analysis was performed using Tukey’s Test
with significance set at P < 0.05. The correlation between
the RT-qPCR results and miRNA-sequencing results was
determined using Pearson correlation coefficient per-
formed in the “Hmisc” package in R with significance
set to P < 0.05 [49]. The correlation between the expres-
sion patterns of each miRNA and its putative target
mRNAs was determined using Pearson correlation coef-
ficient during gestation with significance set to P < 0.05
(the false discover rate [FDR] was calculated in the
“p.adjust” function in R) [50]. Negative ΔCT was calcu-
lated for the predicted genes involved in angiogenesis
where ΔCT = (CT values of predicted mRNA - Geometric
mean of the CT values of all three housekeeping genes).
The correlation between target gene’s FPKM and -ΔCT
was evaluated using Pearson correlation coefficient during
gestation due to the normality of the data. Also, the cor-
relation between miRNAs` - ΔCT and their target-genes` -
ΔCT was measured using Pearson correlation coefficient
during gestation.
Mean ISH scores between the two independent ob-
servers were determined, and mean scores were com-
pared between the different stages of pregnancy using
the logistic regression model for overall significance
and Chi square test was used for inter-group (stages of
pregnancy) comparison. Significance was set at P < 0.05.
Due to the non-normal distribution of the ISH scores,
the correlation between the expression levels of eca-miR-
409-3p determined by RT-qPCR and ISH mean scores
was calculated by Spearman correlation (ρ) with signifi-
cance set at P < 0.05.
Results
Differential expression of C24MC-associated miRNAs in
CAM during pregnancy
The expression of 26 mature miRNAs belonging to the
C24MC was quantified in normal equine CAM (n = 29) at
five different stages of pregnancy (45d, 4mo, 6mo, 10mo,
and postpartum) by RT-qPCR (Fig. 2), and the differen-
tially expressed miRNAs (n = 23) during the different
stages of pregnancy are presented in Table 2 (P < 0.05). A
total of 21 miRNAs presented a significantly higher
expression level at 45d followed by a downregulation
later in gestation (Fig. 2 and Table 2). In contrast,
eca-miR-370-3p had a lower expression at 45d of gesta-
tion in comparison to CAM collected at later stages
(Fig. 2 and Table 2). Furthermore, eca-miR-379-5p,
eca-miR-432-5p and eca-miR-487b-3p showed a higher
expression in postpartum samples in comparison to
CAM collected at 6mo. Moreover, eca-miR-3958-3p ex-
pression was significantly higher in postpartum compared
to CAM from 6mo and 10mo of gestation (Table 2). A sig-
nificant positive correlation was observed between the
normalized read counts derived from miRNA sequencing
and -ΔCT values for each of the samples (r ranging from
0.71 to 0.9, P < 0.002) and the overall correlation coeffi-
cient between normalized read counts and -ΔCT was
0.77 (P < 0.001). Four miRNAs out of 30 tested miR-
NAs (eca-miR-136-3p, eca-miR-136-5p, eca-miR-494-
3p, and eca-miR-495-3p) were not expressed in > 50%
of the samples, with some CT values higher than the
accepted range (CT > 35), therefore these miRNAs
were excluded from the dataset.
C24MC-associated miRNA target prediction
Computational target prediction for miRNAs was per-
formed to identify putative mRNA targets and the ex-
pression patterns of predicted target mRNAs present in
CAM were evaluated in an Illumina RNA-sequencing
dataset generated from a subset of samples (n = 16) as
indicated under Materials and Methods, subsection 2.4.
We generated a total of 723 million reads for 16 sam-
ples, and an average of 91.23% (range 89.83 - 92.72%)
of reads were uniquely mapped to the reference gen-
ome (information about individual sample read count
and mapping quality can be found in Additional file 6:
Table S6).
A total of 796 target mRNAs were predicted using
IPA’s microRNA Target Filter function for the differen-
tially expressed miRNAs that presented a significantly
higher expression level at 45d followed by a decline
later in the gestation (n = 21; Table 3). Additionally,
1179 target genes were predicted for this subset of
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miRNAs using mirDB. However, 229/1179 predicted
genes were not expressed in the associated CAM RNA-
seq dataset and were, therefore, excluded from further
analysis (Table 3) (the list of putative target mRNAs for
each miRNA is available in Additional file 7: Table S7).
There was a low agreement between the target lists within
the two programs, which is due to the different algorithms
used by these programs. Since miRNAs mainly down
regulate their target mRNA expression [36, 37], those
mRNAs in the RNA-seq data set which exhibited the
reverse pattern of expression when compared to the
miRNA expression pattern (negative correlation, r ≤ − 0.5,
P < 0.05) were selected for further analysis (Table 4) (n =
130 mRNAs, among which seven mRNAs have been pre-
dicted for more than one miRNA). High expression levels
of C24MC-associated miRNAs in equine CAM collected
at 45d are associated with reduced expression levels of the
predicted mRNA targets with an inverse relationship as
gestational age increases (Fig. 3a and b).
The physiological functions and canonical pathways
for the target mRNAs were predicted using Ingenuity
Pathway Analysis. The predicted physiological function
analysis included involvement in cardiovascular develop-
ment, embryonic development, tissue morphology and
nervous system development and function (Table 5).
Specific functions such as endothelial cell movement/
migration, angiogenesis, differentiation of angioblasts,
formation of vascular plexus, vascularization and morph-
ology of blood vessels were among the annotated cardio-
vascular development processes (Fig. 4a). The expression
pattern of the mRNAs and miRNAs involved in angiogen-
esis and vascular formation during gestation are presented
in Fig. 4b and c, respectively. Interestingly, 31% (8/26) of
the miRNAs evaluated were putatively associated with this
specific biological function. In addition, immunosuppres-
sion and hypersensitivity/immediate hypersensitivity reac-
tions were among the immunological functions assigned
to the predicted targets. The complete list of functions
and diseases associated with this subset of miRNAs can be
found in Additional file 8: Table S8. The canonical path-
ways predicted for the target mRNAs primarily involved
signaling pathways, including axonal guidance signaling,
protein kinase A signaling, cAMP-mediated signaling,
insulin-like growth factor 1 (IGF-1) and insulin receptor
signaling, IL-4 signaling, and MAPK signaling, among
others. The complete list of associated canonical pathways
can be found in Additional file 9: Table S9. Gene ontology
analysis of predicted mRNA targets was performed using
PANTHER, and the biological processes mainly involved
cellular (tyrosine kinase signaling pathway, MAPK cas-
cade, cell proliferation, cycle and growth), metabolic
(hydrolase activity and protein kinase activity), develop-
mental (anatomical structure morphogenesis, cell differen-
tiation, embryo development, ectoderm and mesoderm
Fig. 2 Expression patterns of C24MC-associated miRNAs in CAM during different stages of pregnancy. The heatmap was constructed using -ΔCT
values and scaled for each miRNA. The majority of the miRNAs within the cluster (n = 21) show a significant higher expression at 45d, with
significant downregulation later in gestation. The interactive heatmap can be accessed here. (http://rpubs.com/pouyadini/410338)
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development) and immune system processes (receptor-
mediated endocytosis and phagocytosis) (Fig. 5).
Expression analysis of putative mRNA targets involved in
angiogenesis
Since the top physiological function predicted for tar-
geted mRNAs constituted cardiovascular system devel-
opment (Table 5) and due to the importance of vessel
formation in placenta development and function, we
specifically selected a subset of genes (n = 10) partici-
pating from vascular morphology and cell movement
(Fig. 4a and Additional file 8: Table S8) to confirm their
expression by RT-qPCR during pregnancy in equine
CAM (n = 29). These included ACVRL1, AXL, CXCL10,
DVL1, EDNRA, EPN2, G6PD, JAM2, NRP1 and TYRO3.
There was a significant positive correlation between the
expression pattern evaluated by RT-qPCR and RNA-seq
data (i.e. -ΔCT vs FPKM, 0.6 < r < 0.8 and P < 0.001).
There was also a significant negative correlation be-
tween the expression pattern of miRNAs and their
putative target mRNA (Table 6). The lowest expression
level for these angiogenic-related genes was observed at
45d with a gradual increase in their expression level
toward the end of gestation (Fig. 4d). Interestingly, their
respective miRNAs presented the highest expression at
45d, decreasing thereafter (Fig. 4c). In addition, we
evaluated the putative binding sites between the miR-
NAs and their putative mRNA targets (3’ UTR) and
determined that these occur with a low free energy and,
therefore, these miRNA:mRNA interactions are feasible
(ΔG between − 12.6 and − 32.2; Table 7).
Localization of eca-miR-409 by in situ hybridization
In order to study the cellular and subcellular localization
of one member of C24MC (eca-miR-409-3p) in CAM,
we performed miRNA in situ hybridization (ISH) on
CAM sections during five different stages of pregnancy.
Since eca-miR-409-3p had a differential expression pat-
tern during different stages of pregnancy as determined
by RT-qPCR analyses and presented a 100% homology
Table 2 Differentially expressed C24MC-associated miRNAs during the different stages of pregnancy in equine CAM
miRNA 45 days 4 months 6 months 10 months PostPartum
n = 9 n = 7 n = 4 n = 6 n = 3
eca-miR-127-5p − 0.18 ± 0.2 a −1.14 ± 0.22 b −1.48 ± 0.30 b −1.21 ± 0.24 b − 1.65 ± 0.35 b
eca-miR-134-5p −2.56 ± 0.14 a −3.24 ± 0.16 b −3.75 ± 0.21 b −3.47 ± 0.17 b − 3.5 ± 0.25 b
eca-miR-323-3p − 0.25 ± 0.15 a − 1.27 ± 0.17 b − 2.18 ± 0.23 c −1.9 ± 0.19 b,c −1.55 ± 0.27 b,c
eca-miR-370-3p 2.41 ± 0.16 a 3.38 ± 0.18 b 4.16 ± 0.24 b 3.44 ± 0.2 b 3.97 ± 0.28 b
eca-miR-370-5p −3.58 ± 0.21 a −4.6 ± 0.24 b −5.85 ± 0.32 c − 4.2 ± 0.26 a,b −5.18 ± 0.37 b,c
eca-miR-379-5p 3.84 ± 0.3 a,b 3.7 ± 0.34 a,b 2.85 ± 0.45 a 3.66 ± 0.36 a,b 5.42 ± 0.51 b
eca-miR-382-5p 2.13 ± 0.24 a 0.41 ± 0.27 b − 0.27 ± 0.36 b −0.09 ± 0.29 b 1.2 ± 0.41 a,b
eca-miR-3958-3p 1 ± 0.21 a 0.78 ± 0.24 a,b −0.44 ± 0.29 c −0.2 ± 0.26 b,c 1.22 ± 0.37 a
eca-miR-3958-5p 0.56 ± 0.35 a − 1.98 ± 0.4 b −3.56 ± 0.61 b −1.9 ± 0.43 b −3.45 ± 0.61 b
eca-miR-409-3p 4.62 ± 0.27 a 2.18 ± 0.31 b − 0.26 ± 0.41 c 1.48 ± 0.34 b 1.47 ± 0.48 b,c
eca-miR-411-3p 2.89 ± 0.23 a 0.63 ± 0.26 b −0.04 ± 0.35 b 0.21 ± 0.28 b 0.83 ± 0.4 b
eca-miR-412-3p −4.57 ± 0.19 a −6.20 ± 0.22 b −7.44 ± 0.29 c −6.57 ± 0.24 b,c −6.59 ± 0.34 b,c
eca-miR-412-5p −0.51 ± 0.14 a −1.98 ± 0.16 b −2.89 ± 0.21 c −2.75 ± 0.17 c −2.30 ± 0.24 b,c
eca-miR-432-5p 2.2 ± 0.29 a 1.09 ± 0.33 a,b,c −0.34 ± 0.44 c 0.49 ± 0.36 b,c 2.01 ± 0.51 a,b
eca-miR-433-3p 0.84 ± 0.23 a 0.27 ± 0.27 a,b − 1.27 ± 0.35 c − 0.67 ± 0.29 b,c −0.61 ± 0.41 b,c
eca-miR-485-3p 0.62 ± 0.21 a − 1.18 ± 0.24 b −2.76 ± 0.32 c −1.53 ± 0.26 b,c −2.52 ± 0.37 b,c
eca-miR-485-5p − 2.42 ± 0.11 a −2.92 ± 0.13 a,b −3.43 ± 0.17 b −2.73 ± 0.14 a −2.8 ± 0.2 a,b
eca-miR-487a-5p −1.74 ± 0.14 a −2.48 ± 0.15 b,c −3.56 ± 0.21 d −2.75 ± 0.17 d,b −2.5 ± 0.24 b,c,d
eca-miR-487b-3p 7.11 ± 0.37 a 5.74 ± 0.42 a,b,c 3.11 ± 0.55 d 4.94 ± 0.45 b,c,d 7.24 ± 0.64 a,c
eca-miR-493b-5p −3.79 ± 0.18 a − 4.69 ± 0.21 b −5.93 ± 0.28 c −5.26 ± 0.22 b,c −4.78 ± 0.32 a,b,c
eca-miR-543-3p 1.52 ± 0.2 a 0.07 ± 0.23 b,c − 1.08 ± 0.3 c − 0.29 ± 0.24 b,c −0.17 ± 0.35 b,c
hsa-miR-1247-3p −4.22 ± 0.16 a −5.60 ± 0.18 b −6.83 ± 0.24 c −5.32 ± 0.19 b −6.63 ± 0.27 c
hsa-miR-154-5p 1.13 ± 0.2 a 0.31 ± 0.23 a,b − 0.95 ± 0.3 c − 0.1 ± 0.24 b,c 0.54 ± 0.35 a,b
Data are presented as Mean ± Standard Error of -ΔCT
The expression pattern for each miRNA were compared between timepoints using the mixed model and significant differences between timepoints were
determined by subsequent pairwise comparisons. Thus, differing superscripts indicate significant differences between stages of pregnancy with significance set
to P ≤ 0.05
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to hsa-miR-409-3p, this miRNA was chosen as the best
candidate for ISH analysis. MiR-409-3p signal was sig-
nificantly higher at 45d (mean score of 3.25, P = 0.002),
and its expression showed a decrease towards the end
of pregnancy (Fig. 6c-h). The lowest miR-409-3p signal
was observed at 6mo and 10mo (mean scores of 1, Fig.
6e-f and h). There was a significant correlation between
-ΔCT values and mean ISH scores (ρ = 0.9, P < 0.01). At
45d, miR-409-3p signal was predominantly observed in
the cytoplasm of the chorionic and allantoic epithelium
(Fig. 6c). MiR-409-3p was also abundantly expressed in
mesenchymal cells and vascular endothelium (Fig. 6c).
As indicated above, a significant reduction in miR-409-
3p expression was observed at 4mo, 6mo and 10mo as
well as in postpartum samples. At 4mo, positive signal
was observed in scattered chorionic epithelial cells,
which presented a mild intensity staining (Fig. 6d). Low
signal was observed in the vascular endothelium, allan-
toic epithelium and scattered mesenchymal cells. At
6mo and 10mo, a low expression of miR-409-3p was
observed in the chorionic epithelium, with basolateral
expression in scattered epithelial cells specifically at
10mo (Fig. 6e, f ). Finally, low miR-409-3p expression
was observed in the vascular endothelium of scattered
blood vessels, while no signal was detected in mesen-
chymal cells after 6mo.
Discussion
In the present study, for the first time, we comprehen-
sively and comparatively evaluated the kinetics of the
equine C24MC (26 miRNAs), the ortholog of human
C14MC, in the normal chorioallantoic membrane during
the course of gestation. The chromosome 14 miRNA
cluster, also referred to as the Mirg cluster [19], the
miR-379/miR-410 cluster [51] or the miR-379/miR-656
cluster [13], is one of the largest identified miRNA clus-
ters [14]. This cluster is located at the imprinted domain
on the human 14q32 chromosomal interval (mouse
chromosome 12 and equine chromosome 24) and abun-
dantly expressed in the normal placenta [14]. By evaluat-
ing all sequenced genomes of mammals, it has been
shown that this cluster is preserved without significant
structural changes [13]. For example, all human C14MC
miRNAs are conserved in the equids with the exception
of five (hsa-miR-154, hsa-mir-300, mir-654, hsa-mir-665
and hsa-mir-668). Although human and murine C14MC
Table 3 Number of predicted mRNA targets for a subset of C24MC-associated miRNAs presenting a significantly higher expression
level during early stage of pregnancy (45d, P-value < 0.05), followed by a decline later in gestation as determined by IPA and mirDB
prediction tools
MiRNA ID IPA mirDB Absent in CAM RNA-Seq dataa Common between IPA and mirDB
eca-miR-127-5p 49 72 21 5
eca-miR-134-5p 55 43 9 0
eca-miR-154-5p 28 30 6 6
eca-miR-323-3p 15 110 24 4
eca-miR-370-5p -# 62 12 –
eca-miR-382-5p 10 53 10 2
eca-miR-3958-3p – – – –
eca-miR-3958-5p – – – –
eca-miR-409-3p 7 61 7 1
eca-miR-411-3p 21 71 12 4
eca-miR-412-3p 65 29 11 1
eca-miR-412-5p 31 2 1 1
eca-miR-432-5p 60 44 10 4
eca-miR-433-3p 78 2 – –
eca-miR-485-3p 89 160 27 18
eca-miR-485-5p 174 172 23 28
eca-miR-487a-5p 19 53 13 1
eca-miR-487b-3p 19 4 2 1
eca-miR-493b-5p – – – –
hsa-miR-1247-3p 76 4 3 0
hsa-miR-543-3p – 207 38 –
a predicted genes with mirDB that were not expressed in our RNA-seq dataset from CAM
# There were no predicted targets for this miRNA
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Table 4 Correlation analysis between C24MC-associated
miRNAs presenting a significantly higher expression level during
early stage of pregnancy (45d), followed by a decline later in
the gestation, and that of their putative mRNA targets (n = 130)
MiRNA ID Target mRNA Correlation P value FDR
eca-miR-127-5p MAF1 −0.5982 0.0144 0.049
FBXL15 − 0.5917 0.0158 0.049
ITK − 0.5563 0.0252 0.049
ZNF394 − 0.5381 0.0315 0.049
PEF1 −0.5352 0.0326 0.049
SNX10 −0.5212 0.0384 0.049
YWHAQ −0.5213 0.0384 0.049
CDKN2AIP −0.5065 0.0453 0.049
ALDH1A3 −0.4986 0.0493 0.049
eca-miR-134-5p PLD1 −0.7269 0.0014 0.003
SLC14A1 −0.5934 0.0154 0.015
eca-miR-323-3p CREBL2 −0.7515 0.0008 0.006
AFTPH −0.6925 0.0029 0.010
DNAJC6 −0.6175 0.0108 0.017
TMEFF2 −0.6123 0.0117 0.017
PDE4B −0.6045 0.0131 0.017
TAF12 −0.5981 0.0144 0.017
IGSF3 −0.501 0.048 0.048
eca-miR-370-5p ZMAT3 −0.5327 0.0336 0.049
DCDC2 −0.5266 0.0361 0.049
PLEKHA3 −0.4989 0.0492 0.049
eca-miR-382-5p JAM2 −0.7504 0.0008 0.002
KLHL36 −0.5945 0.0152 0.015
eca-miR-409-3p TM4SF18 −0.7353 0.0012 0.005
MME −0.6665 0.0048 0.010
HBP1 − 0.6237 0.0098 0.012
TNFSF14 −0.609 0.0123 0.012
eca-miR-411-3p SEC24B −0.8907 < 0.0001 0.001
CXCL10 −0.7036 0.0024 0.011
CC2D2A −0.6435 0.0072 0.016
MKS1 −0.6361 0.0081 0.016
EXO5 − 0.6303 0.0089 0.016
KRCC1 −0.6139 0.0114 0.017
CADM1 −0.5907 0.016 0.019
TSHZ1 −0.5881 0.0166 0.019
DUSP10 −0.5092 0.044 0.044
eca-miR-412-3p GABARAPL1 −0.6578 0.0056 0.017
STARD3NL −0.5598 0.0241 0.036
MBTPS1 −0.5005 0.0483 0.048
eca-miR-412-5p SRL −0.6407 0.0075 0.008
eca-miR-432-5p AXL −0.5358 0.0324 0.035
CYP46A1 −0.5283 0.0354 0.035
Table 4 Correlation analysis between C24MC-associated
miRNAs presenting a significantly higher expression level during
early stage of pregnancy (45d), followed by a decline later in
the gestation, and that of their putative mRNA targets (n = 130)
(Continued)
MiRNA ID Target mRNA Correlation P value FDR
eca-miR-433-3p PPP3R1 −0.6886 0.0032 0.022
CTNNAL1 −0.6311 0.0088 0.031
AXL −0.5933 0.0154 0.036
FAM107A −0.5457 0.0288 0.044
SH3BGRL −0.5383 0.0315 0.044
CYP46A1 −0.5234 0.0375 0.044
MARK3 −0.5077 0.0447 0.045
eca-miR-485-3p CHKA −0.797 0.0002 0.003
CCDC68 −0.7795 0.0004 0.003
PLCL2 −0.7534 0.0008 0.004
AKAP1 −0.6916 0.003 0.011
CD36 −0.6645 0.005 0.011
NR1D2 −0.6638 0.005 0.011
RAB30 −0.6624 0.0052 0.011
FAM26E −0.6531 0.0061 0.011
TTC39A −0.629 0.009 0.015
NTRK3 −0.6146 0.0113 0.017
BRD3 −0.5751 0.0198 0.027
GPAM −0.5536 0.0261 0.033
ZNF322 −0.533 0.0335 0.039
PPP3R1 −0.5107 0.0432 0.046
EDNRA −0.4982 0.0495 0.049
eca-miR-485-5p ACACB −0.7863 0.0003 0.005
SNX27 −0.7736 0.0004 0.005
SSH3 −0.7668 0.0005 0.005
TYRO3 −0.7498 0.0008 0.005
ITPRIP −0.752 0.0008 0.005
CDC42BPA −0.7137 0.0019 0.008
FADS3 −0.706 0.0022 0.008
DFFA −0.6948 0.0028 0.008
KNOP1 −0.6954 0.0028 0.008
MSI2 −0.6903 0.0031 0.008
VDR −0.6906 0.0031 0.008
OLFML2A −0.6713 0.0044 0.011
NXN −0.6692 0.0046 0.011
IRAK4 −0.6638 0.005 0.011
KDSR −0.6498 0.0064 0.013
INPP5B −0.6389 0.0077 0.014
C10orf76 −0.6302 0.0089 0.016
PEX11B −0.6178 0.0108 0.017
TMUB2 −0.6162 0.011 0.017
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and C12MC do not encode miR-3958 and miR-3959,
these miRNAs have been predicted in equine C24MC
and ovine C18MC orthologous clusters. This is the first
report to unequivocally confirm the expression of the
predicted eca-miR-3958-3p and eca-miR-3958-5p in
equine CAM tissues. Here, we determined a significantly
higher expression level of these miRNAs at 45d followed
by a decline with increasing gestational age, demonstrat-
ing that these miRNAs have a similar expression pattern
as other members of C24MC. Since current search data-
bases for the identification of mRNA targets are based
solely on human and murine miRNA annotation, predic-
tion of eca-miR-3958-5p specific mRNA targets could
not be performed. Currently, their predicted mRNA tar-
gets remain unknown and, therefore, identification of
these targets is required to gain further insight into their
functional role during gestation.
In previous studies, it has been shown that C14MC in
humans is expressed predominantly during the first tri-
mester of pregnancy and that its expression decreases as
pregnancy advances [11, 23]. Morales-Prieto et al. ana-
lyzed the expression of C14MC in human cytotropho-
blast cells collected from healthy first trimester placenta
and term placenta (collected from postpartum samples)
and showed that the expression of miRNAs within
C14MC decreases significantly from first to third trimes-
ter [11]. This conclusion was based on a decline in ex-
pression levels of 16 miRNAs at only two time points. A
recent study also observed the same expression pattern
for six miRNAs within this cluster in villous tissue from
human placenta obtained at the first trimester of preg-
nancy and postpartum placenta [23]. In the present
study, we examined the expression kinetics of
C24MC-associated miRNAs at five gestational time
points in the entire CAM. Similar to human C14MC, we
Table 4 Correlation analysis between C24MC-associated
miRNAs presenting a significantly higher expression level during
early stage of pregnancy (45d), followed by a decline later in
the gestation, and that of their putative mRNA targets (n = 130)
(Continued)
MiRNA ID Target mRNA Correlation P value FDR
EFR3B −0.5739 0.0201 0.030
TMEM86A −0.5483 0.0279 0.039
G6PD −0.5467 0.0284 0.039
TMEM104 −0.5282 0.0355 0.045
TMEM120B −0.5276 0.0357 0.045
ACVRL1 −0.5224 0.0379 0.045
AP3S2 −0.5101 0.0435 0.048
PPP1R13B −0.5101 0.0435 0.048
ZNF256 −0.5015 0.0478 0.049
SEMA4D −0.5011 0.048 0.049
UAP1L1 −0.4978 0.0497 0.049
eca-miR-487a-5p TSPAN3 −0.7604 0.0006 0.005
KIF13A −0.738 0.0011 0.005
SEMA3D −0.678 0.0039 0.009
NSMF −0.6753 0.0041 0.009
CDKN2AIP −0.5968 0.0147 0.026
SORBS1 −0.5357 0.0325 0.042
AKAP6 −0.5302 0.0346 0.042
DACH1 −0.5236 0.0374 0.042
AKTIP −0.4985 0.0494 0.049
eca-miR-543-3p NR3C1 −0.6944 0.0028 0.024
RPAP2 −0.6608 0.0053 0.024
NR1D2 −0.6509 0.0063 0.024
GPCPD1 −0.6264 0.0094 0.024
BTBD3 −0.6199 0.0104 0.024
LRRC8D −0.6084 0.0124 0.024
MSL2 −0.5954 0.015 0.024
TP53INP1 −0.5911 0.0159 0.024
HSPA12A −0.5872 0.0168 0.024
ARMC8 −0.5759 0.0196 0.025
PLEKHA8 −0.5341 0.0331 0.039
BCL6B −0.5266 0.0361 0.039
API5 −0.5109 0.0431 0.043
hsa-miR-1247-3p RHOBTB2 −0.7882 0.0003 0.003
GRB7 −0.7564 0.0007 0.004
KDSR −0.6962 0.0027 0.008
GLP1R −0.6809 0.0037 0.008
DVL1 −0.677 0.004 0.008
AGFG2 −0.6728 0.0043 0.008
EPN2 −0.6434 0.0072 0.011
ACVRL1 −0.5895 0.0162 0.022
Table 4 Correlation analysis between C24MC-associated
miRNAs presenting a significantly higher expression level during
early stage of pregnancy (45d), followed by a decline later in
the gestation, and that of their putative mRNA targets (n = 130)
(Continued)
MiRNA ID Target mRNA Correlation P value FDR
WNT9B −0.5606 0.0239 0.028
NRP1 −0.5567 0.0251 0.028
SEMA6D −0.5216 0.0383 0.038
hsa-miR-154-5p HECTD4 −0.6384 0.0078 0.018
SALL1 −0.6115 0.0118 0.018
C12orf29 −0.5164 0.0406 0.041
The miRNA expression was evaluated by RT-qPCR (− ΔCT) and the respective
mRNA expression was determined by RNA-sequencing (FPKM)
Since miRNAs down regulate their target mRNA/s expression, those target
mRNAs in the RNA-seq dataset that exhibited the reverse pattern of
expression compared to the miRNA expression pattern (negative correlation,
r ≤ −0.5, P < 0.05) were selected. There was no significant correlation between
the expression pattern of eca-miR-487b-3p and that of its predicted targets
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determined that the majority of the evaluated miRNAs
(21/26) were highly expressed at the beginning of preg-
nancy followed by a decline towards the end of pregnancy.
Accordingly, we observed a similar pattern of expres-
sion for miR-409-3p, a C24MC member, by ISH and
we determined the cellular localization of this miRNA
within CAM during the course of gestation. It is
important to notice that, although some miRNA se-
quences from this cluster overlap with specific genes
in the opposite DNA strand, the high RIN values in
the samples evaluated determine the reliability of the
miRNA expression analysis performed herein. This is
further supported by the fact that ongoing studies in
our laboratory to elucidate the interplay between
eca-miR-127 and RTL1, encoded in opposite DNA
strands, demonstrated that the expression of these ex-
hibit a negative correlation during pregnancy whereby
expression of eca-miR-127 decreases throughout ges-
tation while that of RTL1 increases (Dini and Ball,
2018, unpublished).
Fig. 3 a. Expression patterns of mRNAs targets which presented a significant negative correlation to their respective miRNA expression during
gestation. The heatmap was constructed using FPKM values and scaled for each mRNA target. The interactive heatmap can be accessed here.
(http://rpubs.com/pouyadini/337845). b. Comparative expression analysis between C24MC miRNAs (n = 21) and putative mRNA targets (n = 130) in
equine CAM throughout pregnancy demonstrates a negative correlation in their overall expression pattern (r = − 0.78; P < 0.05). Correlation was
calculated between the average expression pattern of C24MC-associated miRNA (n = 26 [no postpartum samples]) and the average expression
pattern of predicted target mRNA (n = 16). Mean values ± standard error of the means are depicted
Dini et al. BMC Genomics          (2018) 19:954 Page 13 of 21
Several studies have been published on the import-
ance and functions of miRNAs on placental perform-
ance [52, 53]. For example, by restricting genes
encoding critical miRNA biosynthetic enzymes such as
Dicer [54] or Ago2 [55, 56], normal placental function
was impaired, leading to early post-implantation embry-
onic lethality in mice. Others have used more targeted
murine gene knockout experiments to elucidate miRNA
functions in the placenta [57]. Even though these experi-
mental functional analysis are available, they are limited to
small number of miRNAs and target genes [35]. The find-
ings presented herein suggest that the differential expres-
sion of several miRNAs within C24MC may be associated
with placental development and performance during the
course of gestation. In that regard, experimentally evaluat-
ing their functional role in vivo or in vitro constitutes a
challenging task, particularly for a cluster of miRNAs.
Thus, computational prediction of miRNA targets is the
main tool for identifying possible miRNA:mRNA interac-
tions and miRNA functions when a group of miRNAs are
studied simultaneously [35, 58]. Computational algorithms
can generate a list of putative genes targeted for the
miRNA of interest; however, the presence of these genes
in the specific cell or tissue of interest is not guaranteed.
Another drawback of computational target predictions
involves the occurrence of false putative targets (false
positives). It has been shown that most of the target pre-
diction algorithms have false positive rates of several tens
of percent and, thus, may compromise functional infer-
ences [59–61]. In the current study, to assess the pre-
dicted targets and have an insight into the functional role
of C24MC-associated miRNAs in CAM, we generated
an RNA-seq dataset from the same sample set to
characterize the specific transcriptome profile of equine
CAM throughout pregnancy as an alternative approach
to specifically identify our predicted miRNA-targeted
genes in the tissue of interest (CAM) with a higher confi-
dence. Initially, we confirmed the presence of predicted
target mRNAs in CAM tissue, followed by extensive cor-
relation analysis between the expression profile of each
miRNA with that of its predicted target mRNAs through-
out pregnancy. It is well-known that miRNAs downregu-
late their target mRNA expression and, therefore, the
expression pattern of specific miRNAs and that of their
targets tend to be negatively correlated [36, 37]. We ana-
lyzed the negative correlation for the predicted targets and
were able to narrow the list of putative targets to 130
genes (out of 1975 initially predicted). We believe this ap-
proach provided us with a more representative putative
target list for C24MC in equine CAM.
Several functions have been proposed for this cluster
including immune suppressive functions, participation in
the anti-inflammatory response, protection from the is-
chemic/hypoxia injury, cell motility and participation in
angiogenesis [10, 11, 51, 62]. It has been shown that
C14MC has a pivotal effect on the feto-maternal inter-
face of the placenta specifically on development of the
endothelial and trophoblast cell interaction [19, 63, 64].
Mice with knockout C14MC had severe abnormalities
associated with fetal capillaries in the placenta [63]. This
capillary abnormality leads to overgrowth of the pla-
centa, due to the large number of vacuoles in endothelial
cells and the surrounding trophoblast layer of the fetal
capillaries in the labyrinth zone causing neonatal lethal-
ity [63]. Interestingly, it has been shown that disruptions
in the expression of this cluster in tissues other than pla-
centa are related to vascular invasion [65]. In line with
this, our computational target prediction analysis sug-
gested that miRNAs from the C24MC target specific
mRNAs involved in angiogenesis, angiogenesis of tissue
of epithelial origin, vascularization, and development
and migration of endothelial cells. Also, in another
knockout model in mice, it has been shown that murine
C12MC plays a number of roles required for neonatal
survival [19]. Additionally, in vitro studies have shown
that several miRNAs regulate trophoblast cell prolifera-
tion, invasion, and angiogenesis [66]. Consequently, the
changes in the expression of C24MC-associated miRNAs
during the course of pregnancy suggest that this may
lead to modifications in angiogenesis within the placenta
as pregnancy advances. For instance, it has been shown
that CXCL10, which is a target gene for miR-411, can
modify the development of newly formed vasculature
[67]. We hypothesize that the reduction in the expres-
sion of some of the miRNAs in this cluster triggers the
upregulation of angiogenesis-related genes that allow the
process of angiogenesis to occur as the placenta de-
velops. Here, we investigated the expression pattern of
10 selected putative mRNAs including CXCL10 during
the course of gestation and demonstrated a negative cor-
relation with the respective miRNAs targeting this set of
genes. For instance, the low expression of these mRNAs
Table 5 The physiological function analysis prediction for the
putative mRNA targets of C24MC-associated miRNAs with a
significantly higher expression level during early stages of
pregnancy (45d), followed by a decline toward the end of the
gestation
Physiological Function
P value range Number of
genes involved
Cardiovascular System
Development and Function
7.68E-03 - 2.63E-06 26
Tissue Morphology 8.79E-03 - 2.63E-06 49
Embryonic Development 8.99E-03 – 1.83E-05 36
Nervous System Development
and Function
8.72E-03 – 2.18E-05 30
Behaviour 5.81E-03 – 4.50E-05 22
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Fig. 4 (See legend on next page.)
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at 45d was accompanied by a high expression of their re-
spective miRNAs. Furthermore, estimation of the miRNA
binding sites at the 3’ UTR of their respective (predicted)
mRNA targets demonstrated that all of the putative miR-
NA:mRNA interactions occur with a low free energy,
which is indicative that these RNA:RNA interactions are
feasible. Even though these results suggest the potential
influence of these miRNAs in the regulation of this set of
angiogenic genes, further in vivo or in vitro studies to elu-
cidate the effect of these miRNAs on angiogenesis during
placental development are warranted.
Finally, we localized eca-miR-409-3p in CAM and com-
pared its expression during different stages of pregnancy.
Our data suggest that the expression level and localization
of this C24MC-associated miRNA is dependent upon the
developmental stage of the CAM. While eca-miR-409 ex-
pression was high in the chorion and allantoic epithelia,
mesenchymal cells and vascular endothelium in early
pregnancy (45d), its expression was significantly reduced
after 4mo with gradual loss of expression in these cell
types. The downregulation of this miRNA in vascular
endothelial cells along with an increase in the expression
(See figure on previous page.)
Fig. 4 a. Pathway analysis of negatively correlated target mRNAs (n = 130) for differentially expressed C24MC-associated miRNAs presenting a
decline in their expression during the course of gestation. Target mRNAs were mainly associated with cardiovascular development and function,
and included endothelial cell movement/migration, angiogenesis, differentiation of angioblasts, formation of vascular plexus, and vascularization
and morphology of blood vessels. Specific C24MC-associated miRNAs and direct relationships are shown in blue. Relevant physiological
functions/pathways involved and their direct relationships are depicted with varying sizes according to the associated number of target mRNAs
(ie. larger size indicative of higher number of mRNAs involved). The interactive figure can be accessed here. (http://rpubs.com/pouyadini/431871)
b. Expression patterns of mRNAs (n = 29 putative targets), which presented a significant negative correlation to their miRNA expression during
gestation and are predicted to be involved in angiogenesis. The heatmap was constructed using FPKM values and scaled for each mRNA. The
interactive heatmap can be accessed here. (http://rpubs.com/pouyadini/339221) c. Expression patterns of miRNAs (n = 8), which were predicted
to be involved in angiogenesis in CAM during different stages of pregnancy (n = 29 samples). The heatmap was constructed using -ΔCT values
and scaled for each miRNA. The interactive heatmap can be accessed here. (http://rpubs.com/pouyadini/391422) d. Expression patterns of
putative mRNA targets involved in angiogenesis (n = 10) during the course of gestation in CAM (n = 29 samples). The heatmap was constructed
using -ΔCT values and scaled for each mRNA. The interactive heatmap can be accessed here. (http://rpubs.com/pouyadini/391679)
Fig. 5 Functional annotation analysis of predicted mRNA targets using PANTHER
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of angiogenic genes further suggests that this miRNA
cluster is likely involved in the regulation of angiogenesis
during placental development. Moreover, there was a
significant correlation between expression levels of this
specific miRNA determined by RT-qPCR and ISH. This is
the first report on the expression of one of the C24MC
members at the cellular and subcellular level in CAM
throughout the pregnancy. The differential expression pat-
tern of this miRNA suggests its role during pregnancy is
dynamic and dependent on the stage of gestation.
Conclusion
In conclusion, for the first time, we have comprehen-
sively evaluated the kinetics of the C24MC in CAM,
orthologous to the human C14MC, during equine preg-
nancy. We demonstrated that the expression of
C24MC-asssociated miRNAs decreased during the
course of gestation. We generated an RNA-seq dataset
from equine CAM during pregnancy and predicted the
functions of C24MC-associated miRNAs in this tissue.
We have correlated the expression profile of C24MC-as-
sociated miRNAs and targeted mRNAs to evaluate the
role of this cluster in the modulation of gene expression
during placental development in vivo. We observed an
Table 6 Correlation analysis between selected target genes
associated with angiogenesis and the respective members of
C24MC in CAM during different stages of pregnancy (n = 29
samples)
Target mRNA MIRNA ID Correlation P value
ACVRL1 hsa-miR-1247-3p −0.72 < 0.0001
ACVRL1 eca-miR-485-5p −0.54 0.0024
AXL eca-miR-433-3p −0.65 0.0001
AXL eca-miR-432-5p −0.55 0.0022
CXCL10 eca-miR-411-3p −0.75 < 0.0001
DVL1 hsa-miR-1247-3p −0.60 0.0006
EDNRA eca-miR-485-3p −0.60 0.0007
EPN2 hsa-miR-1247-3p −0.53 0.0026
G6PD eca-miR-485-5p −0.58 0.0010
JAM2 eca-miR-382-5p −0.59 0.0009
NRP1 hsa-miR-1247-3p −0.58 0.0009
TYRO3 eca-miR-485-5p −0.57 0.0012
Table 7 Putative mRNA:miRNA binding site and the free energy (ΔG)
Target mRNA MIRNA ID ΔG 3′ UTR binding site (5′ to 3′) Position at 3′UTR MIRNA seed sequence Seed sequence position
ACVRL1 hsa-miR-1247-3p −25.4 UCCUGGG 799-805 CCCGGGA 2-8
ACVRL1 hsa-miR-1247-3p −20.6 CCUGGG 590-595 CCCGGG 2-7
ACVRL1 eca-miR-485-5p −26.2 GCCAGCCUC 560-568 GAGGCUGGC 2-10
ACVRL1 eca-miR-485-5p −23.1 AGCCUC 455-460 GAGGCU 2-7
AXL eca-miR-432-5p −25.3 UCUAAGA 878-884 UCUUCU 1-7
AXL eca-miR-432-5p −22.7 GCUCUAA 1073-1080 UUGGAGU 3-9
AXL eca-miR-432-5p −21.8 AUUCCAAGG 1245-1254 UCUUGGAGU 1-9
AXL eca-miR-433-3p −20.4 CAUGAU 495-502 AUCACG 1-6
CXCL10a eca-mR-411-3p – – – – –
DVL1 hsa-miR-1247-3p −32.2 CUCGGGG 441-447 CCCGGG 1-7
EDNRA eca-miR-485-3p −12.6 UGUGAC 100-105 GUCAUA 1-6
EPN2 hsa-miR-1247-3p −27.4 CCGGGG 331-336 CCCGGGA 1-6
EPN2 hsa-miR-1247-3p −26.9 CCUGGGG 2087-2093 CCCCGGGA 1-7
EPN2 hsa-miR-1247-3p −25.4 UCUGGGG 366-372 CCCCGGGA 1-7
G6PD eca-miR-485-5p −27.9 CCAGCCUC 409-416 GAGGCUGG 2-9
G6PD eca-miR-485-5p −23.2 GGCCUC 99-105 GAGGCU 2-7
G6PD eca-miR-485-5p −20.9 GUCUGUCUCU 35-44 AGAGGCUGGC 1-10
G6PD eca-miR-485-5p −16.4 CCAGUUUC 514-521 GAGGCUGG 2-9
JAM2 eca-miR-382-5p −20.4 GAGCAAUU 1131-1155 AGUUGUUC 3-10
NRP1 hsa-miR-1247-3p −29.5 CCCGGG 873-879 CCCGGG 2-7
NRP1 hsa-miR-1247-3p −21.5 CCCGGG 821-826 CCCGGG 2-7
TYRO3 eca-miR-485-5p −18 AGUCUCU 899-905 AGAGGCU 1-7
aBinding site and free energy estimation not provided due to the lack of annotation of the 3′ UTR in the current equine genome assembly
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Fig. 6 Localization of miR-409 in CAM samples during the course of gestation by in situ hybridization. NBT/BCIP (blue) was used as the substrate.
Magnification: 200X. Bar = 250 μm. Insets represent a higher magnification (400X). a U6 snRNA control probe exhibits nuclear localization.
b Scrambled miRNA probe (negative control). c CAM collected at 45d shows strong cytoplasmic signal for miR-409 specifically in chorioallantoic
epithelium, vascular endothelium and mesenchymal cells. d and e CAM collected at 4mo and 6mo show a significant reduction in the expression
of miR-409. MiR-409 expression was limited to scattered chorionic epithelial cells (arrows [d]), and rare mesenchymal and vascular endothelial
cells (* [e]). f CAM collected at 10mo shows scattered, basolateral expression of miR-409 in chorionic epithelial cells (arrows) while no expression
was observed in mesenchymal cells. g miR-409 expression was not detected in CAM samples collected postpartum. h The bar graph shows the
mean value for each ISH score with standard error bars in CAM during the course of gestation. Mean miR-409 ISH scores between the two
independent observers were determined, and mean scores were compared between the different stages of pregnancy
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inverse expression pattern for the putative target mRNAs
when compared to the respective miRNA profile. Predict-
ive pathway analysis indicated that members of C24MC
targeted genes relevant to angiogenesis/vascularization, a
process that has an active role during placental develop-
ment and function. Finally, we successfully localized and
evaluated the expression kinetics of a member of this clus-
ter in specific CAM cells during equine pregnancy. Thus,
this study provides fundamental information regarding
the C24MC kinetics during pregnancy that will aid to fur-
ther understand its role during equine gestation. Future
studies to functionally understand the importance of this
miRNA cluster in modulating gene expression during pla-
cental development are warranted.
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